Proxy Votes Now

Home › Funds › Delaware/Macquarie › Nomura VIP Growth and Income Series

Nomura VIP Growth and Income Series proxy voting record 2025-2026

Fund family: Delaware/Macquarie · Filed by DELAWARE VIP TRUST (CIK 814230) · SEC series S000065945

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 650 with, 57 against, 16 abstentions (not counted as with management); 1 split votes are in neither count. Shareholder proposals: 24 FOR, 33 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Delaware/Macquarie as a whole

The same two figures as Delaware/Macquarie’s manager page (15,554 ballot items across 17 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsDelaware/MacquarieItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)93.3%65292.2%13,591
Backed environmental and social shareholder proposals at US companiesn/a3224.8%266

Where this fund voted differently from most Delaware/Macquarie funds

Each ballot item this fund voted is set against the votes of the other Delaware/Macquarie funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Delaware/Macquarie funds on 1 item (0.2% of the 415 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Delaware/Macquarie fundsMgmtResult
Merck & Co., Inc.2026-05-26Election of Directors: Patricia F. RussoForAGAINST — 2 of 3 Delaware/Macquarie fundsForElected, 88.3% support

Download all 1 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 723 such votes could be given a sector.

SectorVotesAgainst managementShare
Finance17674.0%
Consumer Discretionary11565.2%
Health Care11597.8%
Technology1022120.6%
Industrials7245.6%
Telecommunications59711.9%
Energy4824.2%
Consumer Staples2214.5%
Basic Materials1400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5210
Audit-related510
Say-on-Pay510
Corporate Governance3019
Compensation231
Environment or Climate1616
Other Social Issues1413
Capital Structure60
Shareholder Rights and Defenses65
Extraordinary Transactions40

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Micron Technology, Inc.January 15, 2026$110M121
Exxon Mobil CorporationMay 27, 2026$55M172
Cisco Systems, Inc.December 16, 2025$55M131
McKesson CorporationJuly 30, 2025$43M140
Gilead Sciences, Inc.April 30, 2026$43M153
Citigroup Inc.May 20, 2026$39M160
Philip Morris International Inc.May 6, 2026$38M131
Bristol-Myers Squibb CompanyMay 5, 2026$36M151

Notable votes against management

MeetingCompanyProposalFundMgmt
January 15, 2026Micron Technology, Inc.SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposalAgainstFor
May 27, 2026Exxon Mobil CorporationIndependent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposalAgainstFor
May 27, 2026Exxon Mobil CorporationProposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposalForAgainst
December 16, 2025Cisco Systems, Inc.Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 6, 2026Philip Morris International Inc.Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposalAgainstFor
May 5, 2026Bristol-Myers Squibb CompanyShareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 14, 2026AT&T Inc.Shareholder Right to Act by Written Consent Shareholder proposalForAgainst

Search this fund’s votes by company

725 ballot items at 53 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Nomura VIP Growth and Income Series voted at 53 shareholder meetings of 52 companies, on 725 ballot items in all. Where management made a recommendation, the fund followed it on 89.9% of the items and voted against it 57 times. Its most frequent area of disagreement was corporate governance (19 of its votes against management). It voted FOR 42.1% of the 57 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Delaware/Macquarie's funds as a whole (93.3% against 92.2%). It voted differently from most Delaware/Macquarie funds on 1 item.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Delaware/Macquarie’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.